Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma
Authors:
Open Access
- 1 January 2017
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 56 (18) , 2471-2474
Abstract
A 78-year-old man presented with cutaneous blisters of the limbs and abdominal distension. He had been treated for various diseases, including liver cirrhosis. He had begun receiving sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, for diabetes mellitus three years before the hospitalization. A skin biopsy demonstrated bullous pemphigoid. Ultrasonography (US) revealed multiple liver tumors, although he had been receiving regular US studies. We stopped sitagliptin and started insulin and corticosteroids. However, his renal dysfunction progressed, and he died 14 days after the hospitalization. We should therefore be careful of various complications, including bullous pemphigoid and progression of tumors, when using DPP-4 inhibitors.Keywords
This publication has 22 references indexed in Scilit:
- Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance DatabaseBritish Journal of Dermatology, 2016
- Opposing Effects of Antidiabetic Interventions on Malignant Growth and MetastasisCell Metabolism, 2016
- Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance databaseJournal of Clinical Pharmacy and Therapeutics, 2016
- Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to LinagliptinDermatology, 2016
- Drug‐induced pemphigoid: a review of the literatureJournal of the European Academy of Dermatology and Venereology, 2014
- Dipeptidyl peptidase-4: A key player in chronic liver diseaseWorld Journal of Gastroenterology, 2013
- Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patientsJournal of Diabetes Investigation, 2012
- Dipeptidyl peptidase in autoimmune pathophysiology2011
- The Pathophysiology of Bullous PemphigoidClinical Reviews in Allergy & Immunology, 2007
- Distribution of adenosine deaminase complexing protein (ADCP) in human tissues.Journal of Histochemistry & Cytochemistry, 1989